Trial intelligence / Profile preview

Simethicone for early abdominal distension after laparoscopic cholecystectomy

ChiCTR2200064964Phase 4Recruiting

Sponsor
Union Hospital of Huazhong University of Science and Technology
Start
Oct 2022
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, open-label trial of simethicone in abdominal distension (2 arms), sponsored by Union Hospital of Huazhong University of Science and Technology. Primary endpoint: Evaluation of gastrointestinal flatulence during operation. Started Oct 2022; status: recruiting.

02

Drugs

simethicone
03

Conditions

abdominal distension

Beyond the preview

Go deeper on ChiCTR2200064964.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR2200064964.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call